|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
MaxCyte, Inc. Highlights Innovations in Scalable, High-Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
1/22/2013 9:46:40 AM
GAITHERSBURG, Md.--(BUSINESS WIRE)--MaxCyte, Inc., the pioneer in scalable, high performance transient transfection systems, is hosting a series of events at Cambridge Healthtech Institute’s 12th Annual PepTalk to be held January 21-25 in Palm Springs, CA. MaxCyte will present antibody development case studies in a scientific talk, detail breakthrough data in a technical poster, and schedule one-on-one discussions in Booth #307 to demonstrate how the MaxCyte STX® Scalable Transfection System and MaxCyte VLX® Large Scale Transfection System can improve the speed, biologic relevance, and process design for protein and antibody screening and manufacturing.
|
|
|
|
|
|
|
|
|
|
|